Julien T.
- Country
- France
- Department
- Hepatogastroenterology
Research Overview
- Postoperative Hepatic Arterial Oxaliplatin Infusion Combined with Systemic Chemotherapy for High‑Risk Resected Colorectal Liver Metastases: A Randomized Phase II Trial
- Phase II Evaluation of 5-Fluorouracil, Panitumumab, and Sotorasib in First-Line Treatment of Advanced KRAS G12C Mutated Colorectal Adenocarcinoma
Data & Insights
Has run more than one trial at 8 of 103 partner sites.
Specializations
Gastrointestinal Oncology
This investigator specializes in the treatment of colorectal adenocarcinoma, with particular focus on advanced and unresectable cases. Their research encompasses innovative therapeutic approaches for patients with specific genetic mutations.
- Advanced Colorectal Cancer Management
- Targeted Therapy Approaches
- Personalized Treatment Strategies
Precision Medicine
The investigator focuses on mutation-specific treatments, particularly targeting KRAS G12C mutations in colorectal cancer. Their work involves integrating targeted therapies with established treatment protocols.
- Genetic Mutation Analysis
- Targeted Therapeutic Development
- Biomarker-Driven Treatment
Alternative Treatment Pathways
The investigator explores treatment options for patients who cannot undergo conventional chemotherapy regimens. Their research focuses on developing alternative therapeutic approaches for specific patient populations.
- Modified Treatment Protocols
- Patient-Specific Therapy
- Alternative Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.